会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明申请
    • BIOMARKERS FOR PIN1-ASSOCIATED DISORDERS
    • PIN1相关疾病的生物标志物
    • WO2016011265A3
    • 2016-11-17
    • PCT/US2015040771
    • 2015-07-16
    • BETH ISRAEL DEACONESS MEDICAL CT INC
    • LU KUN PINGZHOU XIAO ZHENWEI SHUO
    • C12Q1/68G01N33/53G01N33/68
    • C12Q1/6886A61K9/0019A61K9/06A61K31/203C12Q1/6883C12Q2600/156C12Q2600/158
    • Biomarkers and driver mutations for diagnosis and prognosis of Pin 1 -associated diseases are disclosed. In one embodiment, the methods for diagnosis of Pin 1 -associated diseases may include detecting the level of Pin1 to stage abnormal cell growth, such as breast or prostate cancer. In another embodiment, the methods include evaluating the efficacy of a treatment of abnormal cell growth, such as cancer, by monitoring the levels of Pin1. In another embodiment, the methods include using driver mutations to determine the pharmacogenetics of abnormal cell growth, such as cancer. In the present disclosure, elevated active monomeric Pin1 levels may be detected by Pin1 biomarkers, which may include Pin1 Q33K or E100D driver mutations, Pin1 protein or transcript overexpression, dephosphorylation of Pin1 on Ser71, dephosphorylation of S16, phosphorylation of S65, phosphorylation of S138, deacetylation of Pin1 on K13 and deacetylation of K46, and/or desumoylation of Pin1 on K6 and desumolation of K63, among others.
    • 公开了针1相关疾病的诊断和预后的生物标志物和驱动突变。 在一个实施方案中,用于诊断针1相关疾病的方法可以包括检测Pin1的水平以进行异常细胞生长,例如乳腺癌或前列腺癌。 在另一个实施方案中,所述方法包括通过监测Pin1的水平评价治疗异常细胞生长(例如癌症)的功效。 在另一个实施方案中,所述方法包括使用驱动突变来确定异常细胞生长的药物遗传学,例如癌症。 在本公开中,可以通过Pin1生物标志物检测到活性单体Pin1水平的升高,其可以包括Pin1Q33K或E100D驱动突变,Pin1蛋白或转录本过表达,Ser71上Pin1的去磷酸化,S16的去磷酸化,S65的磷酸化,S138的磷酸化 ,K13上Pin1的脱乙酰化和K46的脱乙酰化,和/或K6上Pin1的去脂化作用以及K63的脱除等。